BONOMINI, Mario
 Distribuzione geografica
Continente #
NA - Nord America 8.518
EU - Europa 6.486
AS - Asia 6.007
SA - Sud America 746
AF - Africa 83
Continente sconosciuto - Info sul continente non disponibili 17
OC - Oceania 11
Totale 21.868
Nazione #
US - Stati Uniti d'America 8.367
SG - Singapore 2.315
CN - Cina 1.938
UA - Ucraina 1.140
IT - Italia 1.138
IE - Irlanda 1.105
TR - Turchia 849
SE - Svezia 738
GB - Regno Unito 659
BR - Brasile 605
DE - Germania 523
FR - Francia 451
IN - India 320
FI - Finlandia 264
VN - Vietnam 255
RU - Federazione Russa 189
CA - Canada 95
HK - Hong Kong 83
PL - Polonia 64
AR - Argentina 46
ZA - Sudafrica 42
AT - Austria 39
CZ - Repubblica Ceca 39
MX - Messico 39
NL - Olanda 36
KR - Corea 35
BD - Bangladesh 33
JP - Giappone 33
EC - Ecuador 31
ES - Italia 27
BE - Belgio 25
ID - Indonesia 22
IL - Israele 15
IQ - Iraq 15
IR - Iran 15
CL - Cile 14
EG - Egitto 14
EU - Europa 14
PY - Paraguay 14
CO - Colombia 13
VE - Venezuela 12
UZ - Uzbekistan 11
AU - Australia 9
AE - Emirati Arabi Uniti 8
JO - Giordania 7
LT - Lituania 7
NP - Nepal 6
TW - Taiwan 6
UY - Uruguay 6
AL - Albania 5
AZ - Azerbaigian 5
DZ - Algeria 5
MY - Malesia 5
PK - Pakistan 5
SA - Arabia Saudita 5
BO - Bolivia 4
DO - Repubblica Dominicana 4
EE - Estonia 4
KE - Kenya 4
NO - Norvegia 4
PS - Palestinian Territory 4
SN - Senegal 4
TN - Tunisia 4
BG - Bulgaria 3
CH - Svizzera 3
DK - Danimarca 3
GR - Grecia 3
LB - Libano 3
LV - Lettonia 3
MA - Marocco 3
QA - Qatar 3
RO - Romania 3
XK - ???statistics.table.value.countryCode.XK??? 3
AM - Armenia 2
BB - Barbados 2
CG - Congo 2
HN - Honduras 2
KG - Kirghizistan 2
MK - Macedonia 2
NZ - Nuova Zelanda 2
PA - Panama 2
PH - Filippine 2
PT - Portogallo 2
BA - Bosnia-Erzegovina 1
BJ - Benin 1
BS - Bahamas 1
BY - Bielorussia 1
BZ - Belize 1
CI - Costa d'Avorio 1
CY - Cipro 1
GD - Grenada 1
GT - Guatemala 1
HR - Croazia 1
IM - Isola di Man 1
JM - Giamaica 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LY - Libia 1
MT - Malta 1
MU - Mauritius 1
Totale 21.860
Città #
Singapore 1.582
Jacksonville 1.276
Dublin 1.092
Chandler 1.052
Ashburn 556
Princeton 517
Southend 450
Beijing 427
Dallas 425
Izmir 418
Nanjing 356
Houston 350
Wilmington 276
Los Angeles 245
Dearborn 219
Cambridge 209
Chieti 184
Santa Clara 163
Tongling 162
Altamura 145
Buffalo 145
Nanchang 143
New York 138
Ann Arbor 130
The Dalles 126
Woodbridge 99
Munich 96
Council Bluffs 92
Ho Chi Minh City 86
Hong Kong 82
Boardman 78
Shenyang 78
Hebei 68
Pescara 66
São Paulo 62
Hefei 57
Washington 57
Dong Ket 55
Redondo Beach 55
Jiaxing 54
Tianjin 54
Kunming 52
Rome 48
Warsaw 46
Nuremberg 37
Hanoi 35
Jinan 35
Brooklyn 34
Helsinki 33
Norwalk 32
Milan 31
Tokyo 31
Brno 30
Hangzhou 30
Atlanta 29
Changsha 29
Johannesburg 29
Montreal 29
Seoul 29
Vittuone 29
Ningbo 28
Chennai 27
London 27
Denver 26
Seattle 26
Brussels 25
Zhengzhou 24
Grevenbroich 23
Chicago 22
Stockholm 22
Bari 21
Ottawa 21
Poplar 21
Vienna 21
Boston 20
Leawood 20
Turku 20
Augusta 19
Toronto 19
Düsseldorf 17
Kocaeli 17
San Mateo 17
Orem 16
Amsterdam 15
Guangzhou 15
Lappeenranta 15
Orange 15
Phoenix 15
Lanzhou 14
Shanghai 14
Bologna 13
Cairo 13
Frankfurt am Main 13
San Francisco 13
Taizhou 13
Ardabil 12
Belo Horizonte 12
Manchester 12
Ankara 11
Catania 11
Totale 13.298
Nome #
[Erythrocyte abnormalities and their possible role in cardiovascular complications of uremia] 427
Therapy of glucocorticoid induced osteoporosis 239
Quali soluzioni future per la dialisi peritoneale? 190
Adherence of Uremic Erythrocytes to Vascular Endothelium decreases Endothelial Nitric Oxide Synthase Expression 171
Epatotossicità acuta da amiodarone endovena in una paziente in emodialisi 168
Plasma protein carbonylation in chronic uremia 160
Effect of an L-carnitine-containing peritoneal dialysate on insulin sensitivity in patients treated with CAPD: a 4-month, prospective, multicenter randomized trial. 153
Prognostic value of morphologic and morphometric analyses in IgA nephropathy biopsies 150
Proteomic investigations on the effect of different membrane materials on blood protein adsorption during haemodialysis 146
Mechanisms of uremic erytrocyte-induced adhesion of human monocytes to cultured endothelial cells 145
Effect of peritoneal dialysis fluid containing osmo-metabolic agents on human endothelial cells 145
Calcium Sensing Receptor Expression in Ovine Amniotic Fluid Mesenchymal Stem Cells and the Potential Role of R-568 during Osteogenic Differentiation 145
Cell activation and cellular-cellular interactions during hemodialysis: effect of dialyzer membrane 144
Calcimimetic R-568 vasodilatory effect effect on mesenteric vascular beds from normotensive (WKY) and spontaneously hypertensive (SHR) rats. Potential involvement of vascular smooth muscle cells (vSMCs) 144
Valutazione dell'utilità del test al Captopril nella diagnostica dell'ipertensione renovascolare (IRV) 143
Adsorption and carbonylation of plasma proteins by dialyser membrane material: in vitro and in vivo proteomics investigations 139
Angiodysplasia of the small bowel: a possible cause of anemia even in mild chronic renal failure 136
Proteomics characterization of protein adsorption onto hemodialysis membranes 134
Proteomic analysis of protein adsorption capacity of different haemodialysis membranes 134
Calcium Sensing Receptor activation by calcimimetic R-568 in human amniotic fluid mesenchymal stem cells: Correlation with osteogenic differentiation. 134
Beta2-microglobulin causes abnormal phosphatidylserine exposure in human red blood cells. 133
Emodiafiltrazione (HDF) con polisulfone (PSF) e neuropatia periferica: una valida alternativa al trattamento emodialitico tradizionale RDT) 132
A new polymethylmethacrylate membrane for hemodialysis 132
Elettrofisiologia del sistema nervoso centrale e periferico in pazienti in trattamento sostitutivo: effetti della RDT e della CAPD 131
Calcimimetic R-568 and its enantiomer s-568 increase nitric oxide release in human endothelial cells 131
Biocompatibility and functional performance of a polyethylene glycol acid-grafted cellulosic membrane for hemodialysis 130
L-carnitine inhibits a subset of platelet activation responses in chronic uraemia 130
Nephrotoxicity induced by chemotherapy [Nefrotossicita' da chemioterapici] 128
Alterazioni del trasporto di Na+ e Ca++ in sinaptosomi di encefalo di ratto uremico: vi è correlazione con la trasmissione sinaptica? 127
Platelet-leukocyte interactions in hemodialysis patients: culprit or bystander? 126
Effect of erythropoietin on primed leucocyte expression profile. 126
Biocompatibility of DIAPES 124
Thyroid function and plasma selenium in chronic uremic patients onhemodialysis treatment 124
Phylogenetic relationships, biofilm formation, motility, antibiotic resistance and extended virulence genotypes among Escherichia coli strains from women with community-onset primitive acute pyelonephritis 124
Proteomic Investigations into Hemodialysis Therapy 124
Carnitine in metabolic disease: potential for pharmacological intervention 121
In vitro microbiology studies on a new peritoneal dialysis connector 120
Thyroid function and selenium supplementation in dialytic patients affected by chronic renal failure 119
Update sull'impiego della proteomica in emodialisi 119
Examining hemodialyzer membrane performance using proteomic technologies 119
Biocompatibility assessment of haemodialysis membrane materials by proteomic investigations 118
Blood cell proteomics in chronic kidney disease 118
Severa neutropenia durante trattamento con amoxicillina/acido clavulanico in un paziente in trattamento emodialitico regolare [Severe neutropenia during treatment with amoxicillin/clavulanic acid in a patient on regular hemodialysis treatment] 118
L-Carnitine is an osmotic agent suitable for peritoneal dialysis 118
Defining the potential antidepressant mode of action of acetyl-l-carnitine. 116
Nitric oxide synthetic pathway and cGMP levels are altered in red blood cells from end-stage renal disease patients 116
Platelet activation markers in patients with nephrotic syndrome: A comparative study of different platelet function tests 113
On-line HFR and removal of uremic toxins inducing the loss of phospholipidic asymmetry of the erythrocyte membrane [HFR on-line e rimozione di tossine uremiche inducenti la perdita dell'asimmetria fosfolipidica della membrana eritrocitaria.] 113
Acetylcholine and acetylcarnitine transport in peritoneum: Role of the SLC22A4 (OCTN1) transporter 113
Dislipidemia e progressione della insufficienza renale cronica 112
Metabolic Syndrome in Survivors from the 2009 Earthquake in Italy 112
Urinary Peptidomic Biomarkers in Kidney Diseases 112
Current opinion on usage of L-carnitine in end-stage renal disease patients on peritoneal dialysis 112
Extra-hepatic manifestations associated with Hepatitis and virus infection 109
Effects of L-carnitine administration on erythrocyte survival in haemodialysis patients 108
Erythropoietin induces miRNA-210 by JAK2/STAT5 signaling in PBMCs of End-stage Renal Disease patients 108
Recovery time after hemodialysis is inversely associated with the ultrafiltration rate. 107
A new form of acute adverse reaction to icodextrin in a peritoneal dialysis patient 106
Cellular properties of human erythrocytes preserved in saline-adenine-glucose-mannitol in the presence of L-carnitine 106
Carnitine palmitoyltransferase as a potential target for treating diabetes: is inhibition or activation preferable? 106
Efficacy of sodium thiosulphate in a case of calciphylaxis in a chronic nephropathic ninety-year-old patient on conservative therapy 106
Enhanced adherence of human uremic erythrocytes to vascular endothelium: role of phosphatidylserine exposure 105
Emodiafiltrazione (HDF) con membrane in polisulfone (PSF) ed eritropoietina ricombinante umana (r-HuEPO): si puo' fare di meglio? 105
Toward personalized hemodialysis by low molecular weight amino-containing compounds: future perspective of patient metabolic fingerprint 105
Uremic toxicity and anemia 104
Use of oral hypoglycemic agents in patients with chronic kidney failure 104
Emodiafiltrazione con polisulfone: effetti elettrofisiologici sulla neuropatia uremica 104
L-carnitine in uremic anemia 104
L-Carnitine status in end-stage renal disease patients on automated peritoneal dialysis 104
Nefropatie tubulo-interstiziali iatrogene: patogenesi e quadro clinico 103
Alterazioni ematologiche nelle malattie renali e alterazioni renali in corso di malattie ematologiche 103
Terapia ipolipemizzante nella insufficienza renale cronica 103
Wireless capsule endoscopy in the diagnostic of small intestine angiodysplasia in chronic uremic patient 103
Selenium in uremia 101
Removal of uremic plasma factors using different dialysis modalities 101
Endoscopy as a tool for diagnosing and treating gastrointestinal angiodysplasia in haemodialysis patients 101
Effetto ipolipemizzante della simvastatina nei pazienti in CAPD con ipercolesterolemia 100
Leukocyte adhesion molecules and leukocyte-platelet interactions during hemodialysis: effects of different synthetic membranes 100
Glomerulopathies associated with psoriasis: a report of three cases 100
New treatment approaches for the anemia of CKD 98
Treatment of cutaneous calciphylaxis with sodium thiosulfate: two case reports and a review of the literature 98
Vascular inflammation in end-stage renal disease: the red blood cell connection 98
Effetto protettivo dei Ca++-antagonisti (CCB) sulla nefrotossicità da ciclosporina (CyA) 97
Calcimimetic R-568 and its enantiomer induce a rapid, reversible, and only partially endothelium-mediated vasodilation in perfused mesenteric arteries from normotensive and spontaneously hypertensive rats 97
Prevalence and associated variables of postdialysis fatigue: results of a prospective multicenter study 97
Terapia sostitutiva artificiale della malattia renale cronica 97
Proteomic Characterization of a New asymmetric Cellulose Triacetate Membrane for Hemodialysis 97
The genetic architecture of membranous nephropathy and its potential to improve non-invasive diagnosis. 97
Biocompatibility of Surface-Modified Membranes for Chronic Hemodialysis Therapy 97
Hemodynamic-guided therapy in essential hypertension: a new pathophysiological approach 96
Management of IgA nephropathy 96
Increased erythrocyte phosphatidylserine exposure in chronic renal failure 96
Proteomic analysis of protein adsorption onto haemodialysis membranes 96
null 96
A rare case of acute tubular necrosis tenofovir alafenamide-related 95
Alterazioni morfo-funzionali dell'apparato cardio-vascolare nei pazienti con malattia renale policistica autosomica dominante 94
ACHIEVEMENT OF NKF/K-DOQI RECOMMENDED TARGET VALUES FOR BONE AND MINERAL METABOLISM IN INCIDENT HEMODIALYSIS PATIENTS: RESULTS OF THE FARO-2 COHORT 94
Effects of selenium supplementation on immune parameters in chronic uraemic patients on haemodialysis 94
Miglioramento dell'attivita' elettrica cerebrale in pazienti uremici in trattamento emodialitico (RDT) dopo eritropoietina umana ricombinante (r-HuEPO) 93
Formalin-fixed paraffin-embedded renal biopsy tissues: an underexploited biospecimen resource for gene expression profiling in IgA nephropathy 93
Totale 12.080
Categoria #
all - tutte 97.044
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 97.044


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.094 0 0 0 0 0 333 15 95 152 272 98 129
2021/20221.147 66 28 30 205 79 22 25 74 102 42 145 329
2022/20233.174 339 382 147 318 283 617 236 225 429 29 94 75
2023/20241.768 110 44 114 55 111 608 384 75 14 35 24 194
2024/20254.068 241 604 465 186 92 126 113 233 593 178 438 799
2025/20263.970 790 377 869 1.058 780 96 0 0 0 0 0 0
Totale 23.314